If you have been reading about research peptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-07-13. Numbers and descriptions here follow the published literature rather than marketing material.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Dihexa is not approved as a medicine in major regulatory jurisdictions. It is commonly sold as a research chemical for laboratory use, though such products may not be standardized or independently verified. Scientific literature on dihexa includes in vitro assays, rodent studies, and reviews that discuss its proposed mechanism. The distinction between peer-reviewed findings and commercial promotion is important when evaluating available information. Open questions include its precise binding interactions, pharmacokinetics, and whether animal results translate to human biology.
Dihexa is a synthetic peptide derived from angiotensin IV, a naturally occurring fragment of the renin-angiotensin system. Researchers modified the angiotensin IV structure to improve metabolic stability and central nervous system activity. It is frequently described as a hepatocyte growth factor mimetic because it can activate the c-Met receptor pathway in experimental systems. Its development reflects interest in small peptides that influence synaptic plasticity and cognitive processes. Most information comes from preclinical studies rather than controlled human trials.
The compound has been examined in animal models for effects on learning, memory, and synaptic connectivity. Some reports describe increased dendritic spine density and improved performance on certain behavioral tasks after administration in rodents. These findings are often cited in discussions of nootropic research peptides, but replication across independent laboratories remains limited. The absence of published phase 1 or phase 2 clinical trial data makes it difficult to assess safety, effective routes, or long-term outcomes in humans. Consequently, claims about cognitive benefits in people remain speculative.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic angiotensin IV analog | Peptidomimetic |
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility | Soluble in DMSO; limited in water | Typical for small peptides |
| Storage | -20 °C, desiccated | Protect from light and moisture |
| Analytical method | HPLC with UV detection | Purity and identity checks |
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Lyophilized dihexa is typically stored as a dry powder at or below minus twenty degrees Celsius. Cooler temperatures slow degradation, and desiccant protection limits moisture uptake. Repeated temperature cycling can accelerate breakdown, so aliquoting before storage is common in laboratory practice. Solutions are generally less stable than dry powder and are often kept cold, protected from light, and used within a defined period. Specific stability data for dihexa are limited, and handling recommendations often follow general peptide guidelines rather than compound-specific studies.
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
== History == The term gynaecomastia was coined by Galen. He also recognised glandular enlargement of the male breast; however, this wasn't a condition of gynaecomastia according to him. A surgical procedure for treatment of gynaecomastia was described by Albucasis in his second book of Kitab al-Tasrif.
== Art == The continuity of the deep fasciae within the human body inspired the artistic expression seen in the Fascial Net Plastination Project, which is prominently displayed at the Body Worlds exhibition in Berlin.
In China and Korea, lotus leaf tea (Korean: 연잎차; RR: yeonnipcha) is made from the leaves of the lotus. Lotus leaves are also used to serve food in various cultures. It is used as a wrap for steaming rice and sticky rice and other steamed dishes in Asian cuisines, such as lo mai gai and zongzi in Chinese cuisine, kao hor bai bua (Thai: ข้าวห่อใบบัว) fried rice wrapped in lotus leaf in Thai cuisine. Vietnamese also use lotus leaves to wrap green young rice, cốm, which is eaten in autumn. The leaves impart a unique scent to the soft, moist rice.
23 February A PAVN rocket attack on Da Nang Air Base destroyed a 450,000 gallon fuel tank beside the base and damaged a Marine A-6 Intruder. PAVN sappers attacked Hill 327 and the positions of the 2nd Battalion 7th Marines northwest of the Hill, both attacks were beaten back with 18 Marines killed and 80 wounded while the PAVN lost 75 killed or captured. A PAVN sapper attack on Dầu Tiếng Base Camp resulted in 21 U.S. and 73 PAVN killed. The PAVN 271st and 272nd Regiments attacked Patrol Base Diamond I occupied by the U.S. 2nd Battalion, 27th Infantry Regiment. The attack was repulsed with artillery and gunship fire with an estimated 118 PAVN killed and two captured.
=== Clinical utility === Most of the metagenomics outcomes data generated consist of case reports which belie the increasing interest on diagnostic metagenomics. Accordingly, there is an overall lack of penetration of this approach into the clinical microbiology laboratory, as making a diagnosis with metagenomics is still basically only useful in the context of case report but not for a true daily diagnostic purpose. As of 2018, cost-effectiveness modelling of metagenomics in the diagnosis of fever of unknown origin concluded that, even after limiting the cost of diagnostic metagenomics to $100 – 1000 per test, it would require 2.5-4 times the diagnostic yield of computed tomography of the abdomen and pelvis in order to be cost neutral and cautioned against ‘widespread rush’ to deploy metagenomic testing. Furthermore, in the case of the discovery of potential novel infectious agents, usually only the positive results are published even though the vast majority of sequenced cases are negative, thus resulting in very biased information. Besides, most of the discovery work based in metagenomic that precedes the diagnostic-based work even mentioned the known agents detected while screening unsolved cases for completely novel causes.
Sources: en.wikipedia.org
Beta blockers act as β-adrenergic receptor antagonists. They may be non-selective, antagonizing both the β1- and β2-adrenergic receptors, or they may be selective for antagonism of the β1-adrenergic receptor (often referred to as "cardioselective"). Some beta blockers have intrinsic sympathomimetic activity (ISA), otherwise known as partial agonist activity at the β-adrenergic receptors with weak sympathomimetic effects. Some beta blockers are not selective for the β-adrenergic receptor and have additional α1-adrenergic receptor antagonism. Some beta blockers have membrane-stabilizing activity, otherwise known as sodium channel blockade or local anesthetic activity. Beta blockers vary in their lipophilicity versus hydrophilicity and hence in their capacity to cross the blood–brain barrier, with some having central nervous system effects and others being peripherally selective.
== Hosts == D. dadantii causes disease on several different ornamental and horticultural host plants throughout the world including: tropical, subtropical, and temperate climates. The host range of D. dadantii continues growing as new susceptible species are continuously being documented. It has also been found in soils, rivers and irrigation water. Host specificity is not yet fully understood. Originally pathovar groups were documented according to the hosts from which they were isolated. Today 50+ species have been identified and more are possible if another classification system based on biovars were to be used. Disease is most often reported on bananas, carnations, and chrysanthemums, but the list of host species is quite vast. Important host families and species economically affected include:
2 HBr → H2 + Br2 (electrolysis of aqueous hydrogen bromide) Br2 + Br− ⇌ Br−3 (initial tribromide production, eventually reverses as Br− depletes) 2 S + Br2 → S2Br2 (bromine reacts with sulfur to form disulfur dibromide) S2Br2 + 8 H2O + 5 Br2 → 2 H2SO4 + 12 HBr (oxidation and hydration of disulfur dibromide)
== Nomenclature == Various names have been applied to the undeclared conflict waged by South Africa in Angola and Namibia (then South West Africa) from the mid 1960s to the late 1980s. The term "South African Border War" has typically denoted the military campaign launched by the People's Liberation Army of Namibia (PLAN), which took the form of sabotage and rural insurgency, as well as the external raids launched by South African troops on suspected PLAN bases inside Angola or Zambia. These occasionally provoked conventional engagements with the Zambian National Defence Force (ZNDF) and the People's Armed Forces of Liberation of Angola (FAPLA). The strategic situation was further complicated by the fact that South Africa occupied large swathes of Angola for extended periods in support of the National Union for the Total Independence of Angola (UNITA), making the "Border War" an increasingly inseparable conflict from the parallel Angolan Civil War. "Border War" entered public discourse in South Africa during the late 1970s; the term was adopted thereafter by the country's ruling National Party. Due to the covert nature of most South African Defence Force (SADF) operations inside Angola, the term was favoured as a means of omitting any reference to engagements on foreign soil. Where tactical aspects of various engagements were discussed, some contemporary historians simply identified the conflict as the "bush war".
=== Cyclic mechanical reinforcement === Most catch bonds were demonstrated using force-clamp force spectroscopy where upon initial ramping, a constant force is loaded on the bond to observe how long the bond lasts, i.e., measuring the bond lifetime at a constant force. Catch bonds are revealed when the mean bond lifetime (reciprocally related to the rate of bond dissociation) increases with the clamped force. Zhu and colleagues demonstrated that bond lifetime measured at the force-clamp phase could be substantially prolonged if the initial ramping included two forms of pre-conditioning: 1) loading the bond by ramping the force to a high level (peak force) before clamping the force at a low level for lifetime measurement, and 2) loading and unloading the bond repeatedly by multiple force cycles before clamping the force at a peak value for lifetime measurement. This new bond type, termed cyclic mechanical reinforcement (CMR), is distinct from catch bond, but it nevertheless resembles catch bond in that the bond lifetime increases with the peak force and with the number of cycles used to pre-condition the bond. CMR has been observed for interactions between integrin alpha 5 beta 1 and fibronectin and between G-actin and G-actin or F-actin.
Sources: en.wikipedia.org
Gastroptosis is the abnormal downward dislocation (ptosis) of the stomach in which its greater curve is displaced below the iliac crest. The stomach is often elongated. The condition frequently causes digestive symptoms, epigastric pain, constipation, gastric reflux, nausea, decreased appetite, gastroparesis (delayed gastric emptying), and in severe cases Median arcuate ligament syndrome. It is much more prominent in women than men, and is diagnosed with x-ray using barium contrast. Gastroptosis is mainly caused by the relaxation of surrounding ligaments and mesenteries as a result of the weight of the stomach and may be due to genetic connective tissue disease.
In 1962, Meurgues' work came to the attention of the botanist Roger Heim. He tasked her with setting up a scientific laboratory in the Muséum national d'histoire naturelle, dedicated to new methods of conservation and presentation of natural history museum collections. This included conservation techniques such as freeze-drying, and resinous injections, the scientific preservation of colours and pigments, as well as improving the interpretation of exhibitions and displays. She organised and directed the laboratory whilst studying for a Diplôme d'études approfondies (Master's degree) in zoology on Calliphoridae, (types of flies) which she completed in 1973. She was promoted to become the museum's assistant professor, and went on collecting expeditions to Kurdistan, Afghanistan, Kashmir, China, Morocco amongst others. Meurgues organised a number temporary exhibitions including: Les pigments végétaux (Vegetable Pigments) in 1963, Orchidées et plantes épiphytes (Orchids and epiphytic plants) in 1966, Météorites, messagères du cosmos (Meteorites, messengers of the cosmos) in 1968, La Nature au microscope électronique (Nature under an electron microscope) in 1971, Le Sahara avant le désert (The Sahara before the desert) in 1974, Les plus beaux coquillages du monde (The most beautiful shells of the world) in 1975, Histoire naturelle de la sexualité (Natural history of sexuality) in 1977 with André Langaney, a leading French science communicator.
== Uses == Radionuclides are used in two major ways: either for their radiation alone (irradiation, nuclear batteries) or for the combination of chemical properties and their radiation (tracers, biopharmaceuticals). For scientific study they may be used for their chemical properties alone when there is no stable form of that element.
Insufficiently controlled type 2 diabetes as an adjunct to diet and exercise As monotherapy when metformin is considered inappropriate due to intolerance In addition to other medicinal products for the treatment of type 2 diabetes Symptomatic chronic heart failure Chronic kidney disease In November 2021, the European Medicines Agency (EMA) stated that dapagliflozin should no longer be used to treat type 1 diabetes.
Sources: en.wikipedia.org
Dihexa is a synthetic peptidomimetic related to angiotensin IV. It is studied in preclinical research for effects on synaptic signaling and cognition. It is not an approved medication.
No major drug regulatory agency has approved dihexa for human use. Published human clinical trials are absent, so its safety and efficacy are not established. It is commonly sold for laboratory research only.
It was developed from research on angiotensin IV analogs and peptide stability. The goal was to find compounds with better brain penetration and metabolic resistance. Early studies used rodent models rather than human participants.
Dihexa is a synthetic peptide derived from angiotensin IV and studied for effects on synaptic plasticity. It is often described as a hepatocyte growth factor mimetic. It is not an approved medication.